Lv11
90 积分 2026-01-26 加入
Tolvaptan in Later-Stage Polycystic Kidney Disease
23天前
已关闭
Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease
29天前
已完结
Long-Acting and Stapled GLP-1R/GIPR/GCGR Triple Agonist for the Treatment of Obesity and Atherosclerosis
1个月前
已完结
Long-Residence Time Peptide Antagonist for the Vasopressin V2 Receptor to Treat Autosomal Dominant Polycystic Kidney Disease
1个月前
已完结
Development of a Long-Acting Interleukin-11 Antagonist for the Treatment of Renal Fibrosis
1个月前
已完结
De Novo Discovery of a Macrocyclic Peptide Antagonist of Interleukin-11 with Antirenal Fibrotic Efficacy
1个月前
已完结
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
8个月前
已完结
Design and Development of a New Glucagon-Like Peptide-1 Receptor Agonist to Obtain High Oral Bioavailability
8个月前
已完结
皖公网安备34019202002308
